Drug Profile
Checkpoint inhibitor - Alpine Immune Sciences
Alternative Names: CD80 vIgD-Fc proteins; Multi-target checkpoint inhibitor - Alpine Immune SciencesLatest Information Update: 12 Dec 2021
Price :
$50
*
At a glance
- Originator Alpine Immune Sciences
- Class Antineoplastics; Proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for research development in Cancer in USA
- 02 May 2017 Early research in Cancer in USA (unspecified route)